We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
David Ilson

David H. Ilson MD, PhD

Attending Physician and Member, Memorial Hospital; Professor of Medicine, Weill-Cornell Medical College

Dr. Ilson completed undergraduate training at the University of Connecticut. He entered an M.D., Ph.D. combined degree program at New York University and received a Masters and Ph.D. degree in Basic Science and M.D. Degree from NYU. He completed his internship and residency in internal medicine at Bellevue Hospital at NYU in New York. He then moved to Memorial Sloan-Kettering Cancer Center and completed a fellowship in medical oncology and hematology. He joined the staff in 1992, becoming a member of the GI Oncology Service in the Department of Medicine, under the direction of Dr. David Kelsen.

Dr. Ilson is now an attending physician and member at Memorial Hospital, and is professor of medicine at Weill-Cornell Medical College. His area of research interest is upper gastrointestinal cancer with a focus on esophageal cancer. His research has focused on the study of new agents in advanced disease, and the evaluation of novel agents in combined modality therapy programs in locally advanced disease. He sits on the GI committees of CALGB and RTOG, and the Upper GI Cancer Guidelines Committee of NCCN. He is chairman on the Intergroup Esophageal and Gastric Cancer Task Force Committee.